Arabic version of the Major Depression Inventory as a diagnostic tool: reliability and concurrent and discriminant validity

The Major Depression Inventory [MDI] is a brief questionnaire to assess the presence of a depressive disorder. We prepared an Arabic version of the MDi and tested its reliability and concurrent and discriminant validity as a diagnostic tool of major depressive disorder. A group of 50 Egyptian outpatients with major depressive disorder [assessed clinically and with the Structured Clinical Interview for DSM-IV-TR Axis 1 Disorders] were compared with 50 healthy controls using the MDI-A, Beck Depression Inventory [BDI] and Spielberger State-Trait Anxiety Inventory [STAI]. Cronbach a was 0.91 and intraclass correlation coefficient was 0.98 [95% Cl: 0.97-0.99]. Scores on the MDI-A strongly correlated with BDI scores [r - 0.81] but insignificantly correlated with STAI scores. Using the MDI scoring algorithm, the sensitivity was 88.4% and specificity 78.9%. We conclude that the MDI-A has an excellent reliability and an acceptable concurrent and discriminant validity

efficacy of different regimens of chlorhexidine as an antimicrobial agent for a group of Egyptians

This study was conducted to evaluate different regimens of 0.12% chlohexidine [CHX] rinse on the salivary parameters and Mutans Streptococci [MS] for a group of Egyptians. Twenty one females were recruited based on inclusive exclusive criteria. They were assigned to three different groups according to the CHX regimen specified. Salivary parameters [unstimulated salivary flow rate, stimulated salivary flow rate, pH and buffering capacity] and salivary mutans streptococci were evaluated at base line for all participants. Diet recording was done for 4 days in a supplied chart. DMFS and DS scores were also determined. This was followed by the use of 0.12% CHX mouth rinse once daily for 60 seconds before bedtime for either 3, 7 or 14 days. Salivary parameters were re-evaluated in the early morning after the use of the mouth rinse, after 1 month and 3 months. Mutans Streptococci [MS] were also evaluated at the same intervals. The salivary parameters did not show any difference throughout the study. The majority of the participants belonged to the moderate low fermentable CHO diet content category and they consumed five meals of cariogenic intake per day. Their DMFS scores ranged between 2 and 50 whereas the DS scores ranged between 2 and 10. The 3 day regimen was not statistically significantly different from the 7 and 14 days regimens and the maximum efficacy of CHX was obtained immediately after its use and lasted throughout the first week after stopping it. The effect of the CHX disappeared after 1 month and gradually reached the base line and surpassed this level sometimes. A regimen of once daily use of 15 ml of 0.12% CHX mouth rinse for 3 days is effective in reducing MS below critical values. It is recommended to reuse the CHX rinse after 1 month owing to the cessation of its effect. Patients who start using CHX should not discontinue it